Sign inJoin waitlistJoin the waitlist

Kent Shih

Physician · OneOncology

Credentials: · · ·

History

OneOncology
Present

Hematology and Medical Oncology
Johns Hopkins University School of Medicine
2000–2003
Internal Medicine
Vanderbilt University Medical Center
1997–2000
Vanderbilt University School of Medicine
1993–1997

Research

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
The Lancet Oncology · 2016 · 955 citations
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Clinical Cancer Research · 2019 · 256 citations
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Journal for ImmunoTherapy of Cancer · 2018 · 236 citations

HB
Howard Burris
8 papers
JH
John Hainsworth
8 papers
DS
David Spigel
5 papers
IB
Isaac Brownell
5 papers
JI
Jeffrey Infante
5 papers
KL
Karl Lewis
5 papers
Omid Hamid
5 papers
Paul Nghiem
5 papers
SD
Sandra D'Angelo
5 papers
Shailender Bhatia
5 papers
David Waterhouse
4 papers
FG
Frank Greco
4 papers

Clinical trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Study chair · Completed · Phase 1
SCRI Development Innovations, LLC
2015–2023
Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma
Study chair · Terminated · Phase 2
SCRI Development Innovations, LLC
2014–2016
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Study chair · Completed · Phase 1, Phase 2
SCRI Development Innovations, LLC
2011–2018